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Background/aim: The aim of this current study was to describe the neuroimaging findings among patients with COVID-19 and to
compare them with thorax CT imaging findings and clinicobiological profiles.
Materials and methods: Between the period March 11 and December 31, 2020, we evaluated brain computed tomography (CT) and
magnetic resonance (MR) images of patients with COVID-19. A total of 354 patients (mean age 65.2 ± 16.6, 52% female, 42% male)
who had brain imaging were included in the study. Of this total sample, 218 had thorax CT scanning (65.5%). Neuroimaging and thorax
CT findings, clinical course, neurologic findings, and laboratory data were evaluated. White matter lesions (WML) and thorax CT scans
were scored. Participants were divided according to whether or not they had an infarction.
Results: The neuroimaging findings indicated infarcts, parenchymal hemorrhage, encephalitis, cortical signal abnormality, posterior
reversible encephalopathy syndrome (PRES), and cranial nerve involvement. WML significantly positively correlated with age (p < 0.01)
but not with sex (p > 0.05). Thorax CT findings did not demonstrate significant correlations with infarcts, WML, or hemorrhages (p
> 0.05). D-dimer and ferritin levels were significantly higher among patients with infarcts (p < 0.05). Conclusion: Immune-mediated
prothrombic state and cytokine storm appear to be more responsible for etiopathogenesis than direct viral neurotropism. Neuroimaging
and thorax CT findings were not correlated among patients with COVID-19 in our study. These results suggest that neurological
manifestations may occur independently of pulmonary involvement and age.
Key words: COVID-19, brain, CT, MR

1. Introduction
Coronavirus disease (COVID-19) caused by the novel
coronavirus severe acute respiratory syndrome—
Coronavirus-2 (SARS-CoV-2) was first reported in
December 2019 in Wuhan, China. Its rapid spread
worldwide has caused more than 119,000,000 infections
and nearly more than 2,600,000 deaths (as of March
15, 2021). The most commonly reported CT findings
in patients with COVID-19 pneumonia were bilateral,
ground-glass opacity in the lower lobes, consolidation,
and a “crazy-paving” pattern [1]. In addition to systemic
and respiratory symptoms of other coronaviruses (CoVs),
the neurologic involvement of SARS-CoV-2 has been
discussed in more detail in recent literature [2-5]. For
example, common manifestations have been described as
headache, dizziness, nausea, ischemic stroke, intracerebral
hemorrhage, epilepsy, myelitis, Guillain–Barré syndrome,
Bell’s palsy, and rhabdomyolysis with decreasing

frequency [6,7]. From initial case reports, COVID-19associated acute hemorrhagic necrotizing encephalopathy
[8], encephalitis/meningitis [9-11], hemorrhagic PRES
[12,13], acute disseminated encephalomyelitis (ADEM)
[14,15], cerebral venous thrombosis [16-18], and acute
ischemic stroke [10,18,19] have also been reported
as other neuroimaging findings. Most neuroimaging
publications about COVID-19 are case reports/series, with
few large patients’ series. The aim of this current study was
to describe neuroimaging findings among patients with
COVID-19 and compare them with thorax CT imaging
findings and clinicobiological profiles.
2. Materials and methods
2.1. Study design and patient cohort
During the period March 11 and December 31, 2020,
we evaluated brain CT and magnetic resonance (MR)
images of patients with COVID-19. Local institutional
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review board approval was obtained from local ethics
committees and the Ministry of Health Scientific Research
Platform for this retrospective study. The requirement for
written consent from patients was waived in accordance
with the Council for International Organizations of
Medical Sciences guidelines. The inclusion criteria
were: i) diagnosis of COVID-19 infection using reversetranscriptase–polymerase-chain-reaction (RT-PCR) or by
chest CT showing results consistent with SARS-CoV-2associated pneumonia, ii) existence of acute neurological
symptoms, iii) age greater than 18 years, and iv) availability
for brain MRI or CT. The exclusion criteria were the
presence of underlying CNS disease, including stroke
and trauma. The neuroimaging and thorax CT findings,
clinical course, neurologic findings, and laboratory data
were acquired from the hospital information system and
picture archiving communication systems (PACS) of our
institution. The D_dimer, C-reactive protein, and ferritin
levels were noted as suspected prognostic laboratory tests
for COVID-19.
2.2. Imaging protocols
Patients were scanned using a 1.5T MRI scanner (Philips
Ingenia®) with a 20-channel head- coil (Philips®, the
Netherlands). The brain MRI protocol included axial T1
weighted (W) conventional spin-echo sequence with and
without gadolinium [repetition time (TR)/echo time (TE):
450/15 ms, slice thickness: 5 mm, field of view (FOV):
230, matrix: 256 × 163; number of excitations (NEX): 2,
intersection gap: 1 mm, scanning time: 2 min 30 s]; axial
T2W turbo spin-echo sequence [TR/TE: 4443/100 ms,
section thickness: 5 mm, FOV: 230, matrix: 384 × 240,
NEX: 2, intersection gap: 1 mm, scanning time: 3 min 37
s], axial and coronal fluid attenuation inversion recovery
[TR/TE/TI: 8000/140/2800 ms, section thickness: 5 mm,
FOV: 230, matrix: 224 × 148, NEX: 2, intersection gap: 0.4
mm, scanning time: 2 min 40 s], sagittal T2W turbo spinecho sequence [TR/TE: 4027/100 ms, section thickness: 5
mm, FOV: 230, matrix: 236 × 205, NEX: 2, intersection
gap: 1 mm, scanning time: 1 min 05 s], and contrastenhanced axial, coronal, and sagittal T1W conventional
spin-echo sequence [TR/TE: 461/10 ms; section thickness:
5 mm, FOV: 230, matrix: 240 × 166, NEX: 2, intersection
gap: 0.89 mm, scanning time: 1 min 43 s]. Diffusionweighted imaging was performed with a single-shot spinecho planar image (ss-EPI) [TR/TE: 3,376/74 ms; section
thickness: 5 mm; FOV: 230 mm; matrix: 128 × 128; NEX:
2; intersection gap: 1 mm; b values: 0 and 1,000 s/mm2].
Imaging parameters for susceptibility weighted imaging
were as follows: TR/TE, 26/50 ms; FA, 20°; slice thickness,
2 mm; slice gap; voxel size 0.9 × 1.06 × 2 mm, 130 slices;
and scanning time: 3′ and 55″. Where encephalitis was
suspected, dynamic susceptibility contrast-enhanced
(DSE) perfusion and MR spectroscopy were acquired.

Brain and thorax CT scans were obtained using a 128-slice
Philips Ingenuity Multidetector CT (Philips Medical
Systems, Best, the Netherlands). The thorax CT parameters
were, respectively, as follows: tube voltage, 100–120 kVp;
tube current, standard (reference mAs; 200–50); slice
thickness, 5.0–5.0 mm; pitch 1.558–1.293. Scans were
taken in the supine position during normal respiration. No
intravenous contrast agent was used. The axial acquisition
non-contrast head CT protocol was as follows: tube
voltage, 135 kVp; tube current, standard (reference mAs;
200–50); with a standard 512 × 512 matrix; and 24 cm
FOV at 5.0 mm section thickness.
2.3. Image analysis
Brain MRI and CT scans were initially analyzed by a
neuroradiologist (H.P.G) with 10 years’ experience and
reviewed for evidence of ischemic infarcts, intracerebral
micro/macro-hemorrhage, edema, venous thrombosis,
cerebral atrophy, PRES, parenchymal and meningeal
enhancement, multifocal white matter lesions (WML),
white and gray matter FLAIR signal abnormalities, and
cranial nerve abnormalities. WML were classified as mild,
moderate, or severe. Participants were divided into two
groups: patients with infarcts (PWI), including with acute/
subacute infarct, and those with any infarct (non-PWI).
Additional findings were noted.
The thorax CT scans were analyzed by a radiologist
(G.R) with six years’ experience of thoracic imaging
at our institution. Evaluation identified ground glass
density, consolidation, and “crazy paving.” These lesions
were scored according to the area of involvement in the
lung. Scoring was performed using the semi-quantitative
method recommended by Pan et al. [20]. Accordingly, the
lesions in all five lobes of the lung were scored visually
between 0 and 5 (where 0 = no involvement, 1 = less
than 5% involvement, 2 = 5%–25% involvement, 3 =
26%–49% involvement, 4 = 50%–75% involvement, and 5
= more than 75% involvement). For each patient, a value
in the range of 0–25 was obtained from the sum of all
lobes. Accordingly, definitions were: mild = 1–9 points,
moderate = 10–19 points, and severe = 20–25 points. No
involvement (0) was considered normal. The radiologists
were blinded from each other while evaluating thorax CT
and brain MRI/CT scans.
2.4. Statistical analysis
Statistical analyses were performed using SPSS version
17.0. Descriptive statistics include the mean (SD) as
median (min–max) or as frequency (%). The Kolmogorov–
Smirnov test was used to analyze the normal distribution
assumption for quantitative outcomes. Due to normally
distributed data, to identify the difference between values,
we used the Student t test for normally distributed data.
Categorical data variables were compared using either
Pearson’s chi-squared test or Fisher’s exact test. The
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correlation coefficient values range from +1 to –1, where
+1 indicates a perfect positive relationship, –1 indicates
a perfect negative relationship, and a 0 indicates no
relationship exists. If the value is near ± 1, then it said to be
a perfect, between ± 0.50 and ± 1, strong, between ± 0.30
and ± 0.49 medium, below + .29 small correlation.

Table 1. Neroimaging diagnosis rates of the patients who died of
COVID-19.
Neuroimaging findings

Percentage

Encephalitis

4%

Cranial nerve involvement

5%

3. Results

Infarct

41%

3.1. Patient characteristics and clinical data
A total of 381 patients who had brain imaging with a
diagnosis of COVID-19 were recruited to the study, and
27 patients (7%) were subsequently excluded following
application of the exclusion criteria. Of the remaining
354 patients (93%) who met the inclusion criteria, 103
(29%) had brain MRI [61 female (59%), 42 male (41%)]
and 254 had brain CT imaging [132 female (51.9%), 122
male (48.1%)]. The mean age of patients who had brain
MRI was 64.4 ± 18.6 years and 69.2 ± 15.3 years for those
who had brain CT. The abnormality detection rate was
4.7% for CT and 28% for MR imaging. The most common
neurologic symptoms were headache (57%), fever (16%),
syncope (13%), weakness (7%), gait disturbance (4%),
and altered mental status (3%). Of the 354 patients who
had neuroimaging, 28 died (6.4%) with accompanying
comorbid factors, such as diabetes mellitus (DM),
hypertension (HT), coronary artery disease (CAD),
demans, and epilepsy (in descending order). Neuroimaging diagnosis rates for patients who died are shown
in Table 1.

Nonspesific

50%

3.2. Neuro-imaging findings
The findings from brain MRI, CT, and diffusion images
revealed infarcts, parenchymal hemorrhages, encephalitis,
cortical signal abnormality, PRES, and cranial nerve
involvement. Brain and diffusion MRI rates are shown in
Table 2. According to MRI findings (n = 103 total), the
WML classification ratios were as follows: none 31% (n =
32), mild 16.9% (n = 17), moderate 19.7% (n = 20), and
severe 32.4% (n =34) in patients.
3.2.1. Infarcts
The ratio of infarcts was 17.5% in total (female = 18.3%,
male 16.6%). The most commonly affected localizations
were the cortical/subcortical area, cerebellum, brain stem,
thalamus/ basal ganglia, watershed zones, and the middle
cerebral artery (MCA)/posterior cerebral artery (PCA)
feeding areas. The distribution of infarcts is shown in
Table 3.
There was no significant difference according to sex,
age, and WML between participants in the PWI and
nonPWI groups (p > 0.05) (Table 4). While male patients
with infarction demonstrated either a moderate or severe
degree of WML, infarctions among female patients were
evident in all degrees of severity. The examples of brain
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Table 2. Brain and diffusion MRI findings rates of COVID-19
patients.
Brain and diffusion MRI findings

Percentage

Normal

63%

Infarct

28%

Hemorrhage

4%

Encephalitis

2%

PRES

1%

Cranial nerve involvement

1%

Cortical signal abnormality

1%

Table 3. The distrubution of occured infarcts.
The distrubution of infarcts

Percentage

Cortical-subcortical

42%

Watersheed zones

8%

MCA-PCA feding zones

4%

Thalamus-basal ganglia

20%

Brain stem

12%

Cerebellum

12%

Corpus callosum

2%

MCA: middle cerebral artery, PCA: posterior cerebreal artery.

stem infarctions are presented in Figures 1a and 1b, and
cerebral infarctions are presented in Figures 1c,1d, 1e, 1f,
1g, 1h.
3.2.2. Parenchymal hemorrhage
Intraparenchymal hemorrhage was identified as macro
and micro hemorrhages in the cerebellar hemisphere
(Figure 2a, 2b, 2c) and MCA territory (Figure 2f, 2g, 2h,
2i), in infarcts. All patients who demonstrated hemorrhage
or hemorrhagic transformation had DM, HT, and CAD as
comorbid factors.
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Table 4. There was no significant difference according to sex, WML, and positive thorax CT findings between participants in the PWI
and nonPWI groups (p > 0.05).
Levene’s Test
for Equality t-test for Equality of Means
of Variances
95% Confidence
Interval of the
Difference

sex
WML
thorax_CT

Equal variances assumed

F

Sig.

t

df

Sig.
Mean
Std. Error
Lower
(2-tailed) Difference Difference

Upper

.457

.500

.325

215

.746

.029

.090

-.148

.206

.323

53.548 .748

.029

.090

-.152

.210

.550

.461

.925

69

.358

.28522

.30847

-.33016

.90060

.936

51.168 .354

.28522

.30471

-.32646

.89689

.232

.28668

.23903

-.18447

.75783

1.185 53.226 .241

.28668

.24193

-.19852

.77188

Equal variances not assumed
Equal variances assumed
Equal variances not assumed
Equal variances assumed
Equal variances not assumed

.063

.802

1.199 215

Figure 1. The examples of infarctions in a 64 years old female in pons (a,b), in a 68 years old man in Broca region (c,d), in 43 years old
man right MCA territory (e,f), in a 32 years old man in left talamus (g,h) on DWI and ADC images (arrows).

3.2.3. Encephalitis
COVID-19-associated encephalitis with a fatal course was
seen in two patients. The first patient was a 54-year-old
female patient admitted to the emergency department with
complaints of respiratory distress and altered mental state.
She had T2/FLAIR hyperintensity with expansion (Figure
3a) and diffusion restriction (Figure 3b, 3c) in the bilateral

thalamus and slightly in the bilateral putamen. In the
follow-up process, the patient had generalized tonic-clonic
seizures and was intubated. Additional neuroradiological
scanning could not be completed, and the patient died
after 11 days.
The second patient was a 49-year-old male patient
admitted to the emergency department with complaints of
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Figure 2. The right cerebellar hemorrhage appearences of a 74 years old man on CT (a) and axial T2W (b), T1W (c) MR images
(arrows). The corpus callosum infarct of a 74 years old man on DWI/ADC (d,e) and microhemorrhages on SWI images (f) (arrows).
The macrohemorrhages of a 64 years old female in the left MCA infarction zones (g,i) and a 46 years old man in the left thalamus (h)
on CT (arrows).

headache, vertigo, and imbalance. He was diagnosed with
DM and COVID-19 disease one month previously. In the first
brain MRI, there were T2/FLAIR hyperintense edematous
signal abnormalities without diffusion restriction in the
right thalamus, basal ganglia, corticospinal tract, and
right side of the brain stem. During the clinical course,
the patient worsened and was intubated. In the follow-up
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imaging, the signal abnormalities extended to bilateral
cerebral hemisphere white matter, the thalamus, basal
ganglia corticospinal tract, brain stem, and cerebellum
(Figures 4a, 4b). Diffusion restriction occurred in the right
thalamus (Figure 4c). There were micro hemorrhages in
the pons and right parietal deep white matter (Figures
4d, 4e, 4f). Perfusion MR imaging highlighted showed
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Figure 3. MRI appearences of a 54 years old female patient show T2 hyperintensity with expansion (a) and diffusion restriction (b,c) in
bilateral thalamus and slightly in bilateral putamen (arrows).

any CBV increment (Figure 4g) and prolongation of
time to peak (Figure 4h) and mean transit time maps
(Figure 4i) in the bilateral thalamus and right temporal
lobe. The patient died four days after initial admission to
hospital, with death recorded as hemorrhagic necrotizing
encephalitis.
3.2.4. Posterior reversible encephalopathy syndrome
The patient with a diagnosis of PRES was a 28-year-old
COVID-19-positive female patient with complaints
of headache, vertigo, and seizure. She also had kidney
transplant history. Brain imaging revealed bilateral
parietal occipital cortical T2/FLAIR hyperintensity
with prominent diffusion restriction and hemorrhagic
transformation seen on the left side (Figure 5a, 5b, 5c).
3.2.5. Cranial nerve involvement
Bilateral trigeminal nerve thickening was revealed by
diffusion MRI in a 67-year-old man with severe COVID-19
pneumonia. Additional cranial nerve involvement and
contrast enhancement could not be revealed due to the
poor clinical course and intubation of the patient (Figure
6a, 6b).
3.3. Thorax CT findings
Of 354 patients who had neuroimaging, 218 had thorax
CT scanning (65.5%). Ground glass density, consolidation,
and crazy paving were noted in the thorax CT evaluation.
Scoring of these lesions was performed using the
semiquantitative method recommended by Pan et al., as
described in the Methods section. Findings such as chronic
airway disease (not defined as a COVID-19-related disease)
were not included in the scoring. According to scoring, the
distribution of thorax CT findings were normal 24.9% (n =
54), mild 33.2% (n = 72), moderate 17.5% (n = 38), severe
10.6% (n = 23), and 13.8% (n = 31) who were nonCOVID.

3.4. Correlations
There was an expected significant correlation between
the WML score and age (r = 0.493, p = 0.001). The WML
score showed no significant correlation with sex (p =
0.076). Thorax CT findings did not achieve significant
correlations with infarcts (p = 0.081), WML (p = 0.121),
or hemorrhages (p = 0.96) (Table 5). One patient who
died from encephalitis had mild pneumonic infiltration.
D-dimer and ferritin levels were significantly higher in
the PWI group compared with the non-PWI group (p =
0.034). The D-dimer, CRP, and ferritin levels showed a
positive correlation with each other in the PWI group (r =
0.482, p = 0.01), and the D-dimer levels were significantly
higher for males than for females (p = 0.037).
4. Discussion
While the general clinical presentation and respiratory
results were speculated aspects of COVID-19, various
neurological manifestations have also been reported during
the course of the disease. The evidence of this retrospective
neuroimaging study demonstrates the association of CNS
involvement with SARS-CoV-2 infection. According to
COVID-19 neuro-imaging reports, the current study
(with a relatively large patient number from a single major
center) has similar patient characteristics in terms of age
and sex [21]. For the distribution of patients who had
neuroimaging and then subsequently died, those without
any pathology ranked first, while those with infarction
ranked second. The most common comorbidities were
DM, HT, and CAD among patients who died from
COVID-19 (due to the exclusion criteria, we did not
investigate patients with chronic neurological disorders).
The most common finding here was that nonspecific imaging findings were compatible with existing
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Figure.4 The brain MRI of a 41 years old male patient with encephalitis showed extensive hypertens signal in bilateral cerebral
hemisphere white matter, thalamus, basal ganglia corticospinal tract, brain stem and serebellum on FLAIR images (a,b). The diffusion
restrction occured only in the right thalamus on DWI sequence (c). There were microhemorrhages in the pons(f) and right parietal
deep white matter (d,e) on SWI images. The perfusion MR imaging showed any CBV increment (g) with prolongation in bilateral
thalamus and right temporal lobe on time to peak (h) and mean transit time (i) maps (arrows).
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Figure.5 The brain MRI of a 28 years old female patient showed bilateral parieto occipital cortical hypointensity on T1W (a),
hyperintensity on T2W (b), and FLAIR (c) images with hemorrhagic transfromation on the left (b) (arrows).

Figure.6 Bilateral trigeminal nerve thickening of a 69 years old man was revealed on DWI (a) and
ADC (b) images (arrows).

literature [22]. Ischemic infarcts were diagnosed in 28%
of our patients, which is similar to findings reported by
Coughar and colleagues [23]. Using MRI in the diagnosis
of infarction may have increased our percentage according
to the literature. The distribution of arterial infarcts
included small vessel, acute large vessel, and watershed
infarcts. We did not describe any venous infarcts or venous
sinus thromboses in our patient cohort. Coagulopathy
is a well-described contributing factor, leading to both
arterial and venous thromboembolic events in patients
with COVID-19 [24]. Therefore, the significant level
of inflammatory markers (such as D-dimer, CRP, and
ferritin levels) confirms this pathway in stroke patients
included in our study. However, it is not clear whether
hyper coagulopathy is related to endotheliopathy by
direct viral infection or from an abnormal inflammatory

response. In our study, the rate of infarction was not
correlated with age, WML, and pneumonic infiltration,
suggesting endothelial damage rather than inflammation.
Accompanying comorbidities such as DM, HT, and CAD
may have contributed to this process with an increased
risk of vasculopathy.
Intracranial hemorrhage in different intracranial
compartments is a common neurologic complication of
COVID-19. Coagulopathies, increased blood pressure,
anticoagulation therapy, disseminated intravascular
coagulation, and cytokine storm with underlying
endoteliopathy may cause micro and macro hemorrhaging.
Patients may present with lobar hemorrhage, subarachnoid/
subdural
hemorrhage,
or
microhemorrhages.
Microhemorrhages may also present as hemorrhagic
transformation of infarcts, as in our patients.
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Table 5. Correlation of neuroimaging findings with age/sex and
thorax CT findings.
Correlated data

p value

WML score / age

r = 0.493, p = 0.001

WML score / sex

r = 0.18, p = 0.076

Thorax CT findings / infarcts

r = 0.36, p = 0.081

Thorax CT findings / hemorrhages

r = 0.49, p = 0.96

Thorax CT findings / WML

r = 0.26, p = 0.121

WML: White matter lesions.

The inflammatory reaction of SARS-CoV-2 with
cytokine storm damages the blood brain barrier and
results in increased vascular permeability in PRES patients.
Patients present with complaints of uncertain symptoms
such as headaches, seizures, and altered consciousness.
Brain MRI typically reveals bilaterally vasogenic edema
in the parietal and occipital regions, with occasionally
accompanying hemorrhagic components [25]. Beside
coagulopathy, the reported acute kidney injury among
COVID-19 patients may lead to rapid changes in blood
pressure, cerebral edema, microembolization, and
microhemorrhages. Our patient with a PRES diagnosis
also had renal transplantation history, which compromises
this suggestion.
Encephalitis is a less common but more critical type
of neuronal involvement of COVID-19. Besides clinical
and laboratory examination, imaging is a powerful tool
for the diagnosis and follow-up of the disease. Described
encephalitis cases present a myriad of radiological
findings and a few reports indicating brain stem and
thalamus involvement, as in our case, which have been
reported previously [8,26,27]. While they may not have
been routinely confirmed by histopathology, the possible
suggested mechanisms present direct viral neuro-invasion
or intracranial cytokine storm and blood-brain barrier
damage.
Cranial nerve involvement involving the olfactory
bulb, optic nerve, abducens nerve, and facial nerve have
been reported previously [28]. To our knowledge, this
is the first presentation of trigeminal nerve involvement
in COVID-19. The involvement of other cranial
nerves and nuclei (except the olfactory nerve) suggests
invasion beyond the olfactory bulb in the course of the
disease. Moreover, according to some authors, it may be
related to axonal spread and viral replication leading to
inflammation and demyelination [29,30]. The inability
to detect SARS-CoV-2 in the CSF until today means the
immunomediated responses may also be responsible for
cranial neuropathies.
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To our knowledge, there is a lack of sufficient data in
the literature to demonstrate the link between COVID-19
neuroimaging and thorax CT findings to date. In our
study, the severity of neuroimaging findings in infarcts
and encephalitis did not correlate with the severity of
thorax CT findings. Some patients had neurological
complaints in the presence of normal thorax CT findings
and any pulmonary symptoms. These findings suggest
a delayed immune-mediated process underlying the
physiopathology of CNS damage regardless of respiratory
involvement [31].
CNS involvement by the virus and subsequent immune
response may be the causes of neuropathology that occurs
with the disease. The hematogenous dissemination of
the virus with infected leukocytes through compromised
endothelial cells of the blood-brain barrier (referred to as
a Trojan horse) is the first mechanism of CNS migration
[32]. The other strongly suggested possible migration
mechanism is the peripheral invasion of the virus through
the olfactory bulb or vagus nerve, which, thereafter,
spreads to different zones of the brain. The infectious
potential of SARS-CoV-2 is based on using angiotensinconverting enzyme 2 (ACE2) pathways to enter cells, as
with other coronaviruses. ACE2 receptors are expressed in
the epithelia of the lung and small intestine and also in the
brain (including neurons, astrocytes, oligodendrocytes,
substantia nigra, ventricles, middle temporal gyrus,
posterior cingulate cortex, and olfactory bulb) [32,33].
Furthermore, the immune-mediated process that causes
cytokine storm is the other underlying neuropathological
pathway of CNS damage observed in COVID-19 [34].
Our study has some limitations. First, it is a retrospective
study, and we did not investigate the patients with chronic
neurological disease where COVID-19 may worsen the
current prognosis. The PCR analysis of COVID-19 from
cerebrospinal fluid could not be evaluated due to a lack of
lab kits. Finally, we could not represent an interobserver
difference in our study.
In conclusion, the increasing frequency of
neuromanifestations of COVID-19 appears in many forms,
including infarcts, WML, PRES, encephalitis, and cranial
nerve involvements. However, this study shows that the
neuroimaging findings do not correlate with age and thorax
CT findings. It seems that neurological involvement tends
to increase in the presence of co-morbid factors such as
HT, DM, and CAD. Although the exact etiopathogenesis
is scant, the immune-mediated prothrombic state and
cytokine storm appear to be more responsible than direct
viral neurotropism. Neuroimaging plays a critical role in
determining neurological complications with significant
mortality and morbidity during the COVID-19 pandemic
process. Further advanced neuroimaging studies with
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diffusion tensor imaging and functional MRI may provide
information on the long-term effects of COVID-19 on the
microstructures of the brain.
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